Track topics on Twitter Track topics that are important to you
MIGDAL HA'EMEQ, Israel, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Enzymotec Ltd., (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid based nutritional ingredients and medical foods, announced today that Dr. Ariel Katz, the Company’s Chief Executive Officer, is scheduled to present at the Jefferies Industrial Conference, being held August 9 – 11, 2016 in New York City and the Canaccord Genuity Annual Growth Conference, being held August 10 – 11, 2016 in Boston.
Details for the Company presentation are as follows:
|Conference:||Jefferies Industrial Conference|
|Date:||Wednesday, August 10, 2016|
|Conference:||Canaccord Genuity Annual Growth Conference|
|Date:||Thursday, August 11, 2016|
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures, and markets innovative bio-active lipid based nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies intended to improve people’s health. For more information, visit www.enzymotec.com.
Contact: The Ruth Group Tram Bui / Lee Roth (646) 536-7035/7012 firstname.lastname@example.org email@example.comNEXT ARTICLE